FDA panel votes 3-14 that Abbott (ABT) has not found right Humira dose
- Stocks Tank as QE Nears End, Major Fund Winds Down, and Ebola Fears
- Traders Eye Relational Investors Stocks on Wind Down
- David Tepper Talks Bonds, Stocks, Fannie/Freddie, Bill Gross and More
- WI-LAN (WILN) Reports Apple (AAPL) Granted Motion for Summary Judgement in Pending Litigation
- Box (BOX) Delays IPO Until 2015 Given Market Conditions - Reports
FDA panel votes 3-14 that Abbott (NYSE: ABT) has not found right Humira dose.
You May Also Be Interested In
- UPDATE: American Airlines (AAL) Flight #AA60 is Declaring an Emergency - Air News
- Abbott Hosts Conference Call for Third-Quarter Earnings
- Abbott Goes Extra Mile in Commitment to Helping People Live Healthy Lives as an Official Sponsor of 2014 Bank of America Chicago Marathon
Create E-mail Alert Related CategoriesFDA, General News
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!